Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Zenotech Laboratories Ltd
Your Vote -
Buy
60.00%
Hold
0.00%
Sell
40.00%
60.00%
5 users have voted
Option Chain
Analyzes market sentiment, predicts Zenotech Laboratories Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Zenotech Laboratorie - Integrated Filing (Financial)
-
Zenotech Laboratorie Q4 net profit jumps 80.88% at Rs 1.23 cr
-
Zenotech Laboratorie - Board Meeting Outcome for Audited Financial Results Of The Company For The Quarter And Financial Year
-
Zenotech Laboratorie - Audited Financial Results For The Quarter And Financial Year Ended March 31, 2025
-
Zenotech Laboratorie - Board Meeting Intimation for Considering And Approving Audited Standalone Financial Results Of The Com
-
Zenotech Laboratorie has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Zenotech Laboratorie - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Zenotech Laboratorie - Announcement under Regulation 30 (LODR)-Change in Directorate
-
Zenotech Laboratorie - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
-
Zenotech Laboratorie - Integrated Filing (Financial)
-
Zenotech Laboratorie - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Key fundamentals
Evaluate the intrinsic value of Zenotech Laboratories Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 96.1308 | 90.5416 | 82.2701 | 76.6401 | 69.0644 |
| Liabilities | 96.1308 | 90.5416 | 82.2701 | 76.6401 | 69.0644 |
| Equity | 61.0306 | 61.0306 | 61.0306 | 61.0306 | 61.0306 |
| Gross Profit | 14.1802 | 17.2225 | 20.7035 | 17.4607 | 6.38 |
| Net Profit | 5.6129 | 8.2987 | 11.5853 | 22.1759 | -1.2151 |
| Cash From Operating Activities | 9.4884 | 11.8226 | 20.6642 | 17.6674 | 5.741 |
| NPM(%) | 13.03 | 20.32 | 27.3 | 60.64 | -5.41 |
| Revenue | 43.0471 | 40.8331 | 42.4243 | 36.5651 | 22.4452 |
| Expenses | 28.8669 | 23.6106 | 21.7208 | 19.1044 | 16.0652 |
| ROE(%) | 6.02 | 8.9 | 12.43 | 23.8 | -1.3 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Zenotech Laboratories Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 824.20 | -1.99 | 11.65 | 31.65 | 1321.50 | 1.39 |
| Lotus Eye Hospital and Institute Ltd | 80.41 | -0.74 | 338.42 | 115.32 | 14.01 | 0.62 |
| Bharat Immunological and Biologicals Corporation Ltd | 23.00 | -1.41 | 0.00 | 239.43 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 681.00 | -1.58 | 0.00 | 108.73 | -687.11 | 0.00 |
Company Info
Sunline Tubes Limited was incorporated on 15th June 1989 under the name MAA SHAKTI TUBE MILL PVT LTD under the Companies Act, 1956 and subsequently its name was changed to SUNLINE TUBES PRIVATE LIMITED and Central government's approval obtained vide letter No.RAP/TA-II/1022/Sec.21/92 dated 1st day of April 1992. Later on the Company was converted into a Public Limited Company and a fresh certificate of incorporation was obtained on 25th August, 1993. The Company was originally promoted by Mr.J.K.Chotalia, Mr.J.Goyani, Mr.N.K.Soni, Mr.Dinesh Kumar Soni and their associates. Later on Mr.Sunil Kumar Giri took over the Company in the year 1992. PRESENT BUSINESS OF THE COMPANY The Company was set up for manufacturing of Lancing Tubes and ERW Tubes with an installed capacity of 5000 MTPA. The company has sucessfully completed its trail production. The Company has sucessfully completed its trail production. The Company now plans to expand its existing production Capacity from 5000 MTPA to 34,000 MTPA and expand its product range to include manufacture of higher dia of up to 6". SUBSIDIARIES OF THE COMPANY: The Company does not have any Subsidiary company. 2004 - Re-issues 31,22,500 Equity Shares, which were earlier forfeited by the company due to non-payment of allotment/call monies 2005 - Company has changed its name from Sunline Technologies Ltd. to Zenotech Laboratories Ltd. 2006 -Zenotech Laboratories enters into strategic alliance with the Ranbaxy 2008 -Zenotech Laboratories has Appointed Mr. Atul Sobti, Mr. Omesh Sethi and Mr. Dipak Chattraj as Non-Executive Directors of the Company 2011 -Mr. I Srinivas has been appointed as Company Secretary cum Compliance officer of the company - Dr. Sudershan K. Arora has been appointed as Executive Chairman of the Company. -Registered Office of the Company has been shifted To Survey No. 250-252, Turkapally Village,Shameerpet Mandal,R.R.District -500078,Andhra Pradesh. 2013 - Mr. Chinmoy Patnaik, Company Secretary and Head of Legal of the Company has been appointed as the Compliance Officer of the Company. 2017 -The company issued rights shares of Rs. 10 in the ratio of 17:22 at a premium of Rs. 35 per share.
Sunline Tubes Limited was incorporated on 15th June 1989 under the name MAA SHAKTI TUBE MILL PVT LTD under the Companies Act, 1956 and subsequently its name was changed to SUNLINE TUBES PRIVATE LIMITED and Central government's approval obtained vide letter No.RAP/TA-II/1022/Sec.21/92 dated 1st day of April 1992. Later on the Company was converted into a Public Limited Company and a fresh certificate of incorporation was obtained on 25th August, 1993. The Company was originally promoted by Mr.J.K.Chotalia, Mr.J.Goyani, Mr.N.K.Soni, Mr.Dinesh Kumar Soni and their associates. Later on Mr.Sunil Kumar Giri took over the Company in the year 1992. PRESENT BUSINESS OF THE COMPANY The Company was set up for manufacturing of Lancing Tubes and ERW Tubes with an installed capacity of 5000 MTPA. The company has sucessfully completed its trail production. The Company has sucessfully completed its trail production. The Company now plans to expand its existing production Capacity from 5000 MTPA to 34,000 MTPA and expand its product range to include manufacture of higher dia of up to 6". SUBSIDIARIES OF THE COMPANY: The Company does not have any Subsidiary company. 2004 - Re-issues 31,22,500 Equity Shares, which were earlier forfeited by the company due to non-payment of allotment/call monies 2005 - Company has changed its name from Sunline Technologies Ltd. to Zenotech Laboratories Ltd. 2006 -Zenotech Laboratories enters into strategic alliance with the Ranbaxy 2008 -Zenotech Laboratories has Appointed Mr. Atul Sobti, Mr. Omesh Sethi and Mr. Dipak Chattraj as Non-Executive Directors of the Company 2011 -Mr. I Srinivas has been appointed as Company Secretary cum Compliance officer of the company - Dr. Sudershan K. Arora has been appointed as Executive Chairman of the Company. -Registered Office of the Company has been shifted To Survey No. 250-252, Turkapally Village,Shameerpet Mandal,R.R.District -500078,Andhra Pradesh. 2013 - Mr. Chinmoy Patnaik, Company Secretary and Head of Legal of the Company has been appointed as the Compliance Officer of the Company. 2017 -The company issued rights shares of Rs. 10 in the ratio of 17:22 at a premium of Rs. 35 per share.
Read More
Parent Organisation
Zenotech Laboratories Ltd.
Founded
15/06/1989
Managing Director
NSE Symbol
FAQ
The current price of Zenotech Laboratories Ltd is
The 52-week high for Zenotech Laboratories Ltd is
The market capitalization of Zenotech Laboratories Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Zenotech Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Zenotech Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Zenotech Laboratories Ltd shares.
The CEO of Zenotech Laboratories Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
